Pages that link to "Q30276065"
Jump to navigation
Jump to search
The following pages link to Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study (Q30276065):
Displaying 13 items.
- Lack of association between cystatin C and different coronary atherosclerotic manifestations. (Q38651014) (← links)
- Factors associated with high brachial-ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors (Q42688068) (← links)
- Letter to the Editor regarding the article 'Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3 (Q50109537) (← links)
- Common Methods for Performing Mendelian Randomization. (Q55030557) (← links)
- Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs? (Q55400363) (← links)
- Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome (Q58121766) (← links)
- Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality (Q59796621) (← links)
- Value of cystatin C in predicting atrial fibrillation recurrence after radiofrequency catheter ablation (Q61454580) (← links)
- Stroke genetics: discovery, biology, and clinical applications (Q64111361) (← links)
- Cardiovascular Risk in Type 1 Diabetes Mellitus. (Q64911301) (← links)
- Serum Cystatin C and Arterial Stiffness in Middle-Aged and Elderly Adults without Chronic Kidney Disease: A Population-Based Study (Q91629328) (← links)
- Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function (Q91976118) (← links)
- Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke (Q93164255) (← links)